Antibodies are incredibly useful. Lots of recently developed drugs rely on antibodies that bind to and block the activity of specific proteins. They’re also great research tools, allowing us to ...

Figuring out how to hack the immune system and make the antibodies we want was just the beginning. Thanks to innovative ...

At the 2022 annual meeting of the American Society of Hematology (ASH), customized cancer immunotherapy treatments now share the limelight with bispecific antibodies, which made news across disease ...

Tel Aviv University researchers have isolated two antibodies that neutralize all known strains of COVID-19 – including Omicron – with up to 95% efficiency. The researchers: Targeted treatment with ...

The part about antibody production for a specific virus not stopping or showing any signs of diminishing after 72 weeks really makes me uncomfortable... It would be helpful if someone can explain if ...

In a groundbreaking leap forward for cancer therapy, scientists in Japan have created a tiny delivery system that helps ...

Antibodies have evolved by nature to possess exquisite selectivity for foreign targets to elicit an effective immune response, making particularly promising strides in advancing drug development for ...

Professor Todd Przybycien, Ph.D., head of RPI’s Department of Chemical and Biological Engineering, has been awarded a $3.1 ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Most people with scleroderma have autoantibodies. Several scleroderma-specific antibodies have been identified. These can help with diagnosis and give insight into the type of disease you may ...

Now that it’s fall, it’s time to get updated on your COVID-19 vaccines if you want to stay protected throughout the winter, when infectious diseases flourish. But does it matter which shot you get?